Skip to main
OMCL

Omnicell (OMCL) Stock Forecast & Price Target

Omnicell (OMCL) Analyst Ratings

Based on 5 analyst ratings
Buy
Strong Buy 20%
Buy 60%
Hold 20%
Sell 0%
Strong Sell 0%

Bulls say

Omnicell Inc has experienced a notable 44% stock increase over the past three months, largely attributed to a $40 million increase in FY25 product revenue guidance. The company's 4Q25 revenue reached $314.0 million, demonstrating a 2.3% year-over-year growth that surpassed the guidance midpoint. Looking ahead, Omnicell projects a revenue of $1,235 million for CY26, indicating a 4.2% year-over-year growth, supported by ongoing product line expansions and an anticipated improvement in margins as new products gain traction.

Bears say

Omnicell Inc. experienced a notable decline in product gross margin, decreasing by 380 basis points quarter-over-quarter largely due to a less favorable product mix within its Connected Devices segment. The company reported mixed financial results for 4Q25, with adjusted EBITDA of $36.8 million and adjusted EPS of $0.40 falling short of guidance expectations, which has contributed to a negative outlook for CY26. Furthermore, the midpoint of the company's CY26 guidance suggests stagnant bookings at $535.0 million, raising concerns about future growth potential as backlog depletion continues without a recovery in revenue from Connected Devices.

Omnicell (OMCL) has been analyzed by 5 analysts, with a consensus rating of Buy. 20% of analysts recommend a Strong Buy, 60% recommend Buy, 20% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Omnicell and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Omnicell (OMCL) Forecast

Analysts have given Omnicell (OMCL) a Buy based on their latest research and market trends.

According to 5 analysts, Omnicell (OMCL) has a Buy consensus rating as of Apr 6, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $53.40, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $53.40, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Omnicell (OMCL)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.